The lancet. Diabetes & endocrinology
-
Lancet Diabetes Endocrinol · Feb 2019
Meta AnalysisChange in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies.
Change in albuminuria as a surrogate endpoint for progression of chronic kidney disease is strongly supported by biological plausibility, but empirical evidence to support its validity in epidemiological studies is lacking. We aimed to assess the consistency of the association between change in albuminuria and risk of end-stage kidney disease in a large individual participant-level meta-analysis of observational studies. ⋯ US National Kidney Foundation and US National Institute of Diabetes and Digestive and Kidney Diseases.